Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2023

Nov 22, 2023

33081_dirs_2023-11-22_2724c4f7-6313-4a73-ac79-a683fa8203fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2023-11-20

Reporting Person: Schornstein Alexander (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-11-20 Common Stock P 300000 $0.718 Acquired 7464292 Direct
2023-11-21 Common Stock P 100000 $0.667 Acquired 7564292 Direct

Footnotes

F1: The sales reported on this Form 4 represent shares purchased by the reporting person from November 20, 2023, to November 21, 2023, from the open market using his personal funds.

F2: The price reported is a weighted average price. These shares were purchased on November 20, 2023, in multiple transactions at prices ranging from $0.695 to $0.72. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.

F3: The 100,000 shares purchased on November 21, 2023, were bought in transactions at prices ranging from $0.6666 to $0.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.